A novel programmed death 1/vascular endothelial growth factor bispecific tumor immunotherapy drug: ivonescimab

doi:10.3969/j.issn.1672-3384.2025.09.005

PDF(501 KB)

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (9) : 26-31. DOI: 10.3969/j.issn.1672-3384.2025.09.005

Comment of New Drug

A novel programmed death 1/vascular endothelial growth factor bispecific tumor immunotherapy drug: ivonescimab

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 23(9): 26-31 https://doi.org/10.3969/j.issn.1672-3384.2025.09.005

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(501 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2025-06-20	2025-09-10
Issue Date
2025-09-26

Please choose a citation manager

Content to export